article thumbnail

New podcast on the future for genomics and big data

Drug Discovery World

This is the latest episode of the free DDW narrated podcast, “What lies in the future for genomics and big data?”, They are called “ What’s the next step in big data and AI? ” and “ Why a recent advancement is a giant leap for human genomics ”.

article thumbnail

What lies in the future for genomics and big data?

Drug Discovery World

This is the latest episode of the free DDW narrated podcast, “What lies in the future for genomics and big data?”, They are called “ What’s the next step in big data and AI? ” and “ Why a recent advancement is a giant leap for human genomics ”. appeared first on Drug Discovery World (DDW).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Digitalising drug discovery

pharmaphorum

The oceans of health data out there can be overwhelming for pharma companies to manage – but if extracted correctly, the prospect to develop drugs from scratch in as little as a year is very real, says Lifebit CEO, Dr Maria Chatzou Dunford. . on Big data: astronomical or genomical? ,

article thumbnail

The DDW Podcast: 2023 in review

Drug Discovery World

In this episode, Kelland shares what she means by the ‘next pandemic’, the lessons learnt from the Covid-19 pandemic, and the role of global health organisations and pharma companies going forward. A deep dive into US drug discovery What lies in the future for genomics and big data? Listen here.

article thumbnail

How digital innovation is helping therapeutics to get to market faster

Drug Discovery World

Biopharma and biotech companies without these capabilities are keen to harness these technologies and the number of strategic partnerships with such companies is accelerating at an unprecedented rate. Automation is also being applied to genomics sample preparation, an area that requires particular robustness and scalability.

article thumbnail

A history of AstraZeneca

pharmaphorum

But although it was dubbed a “dangerous game”, some companies came out on top… On 6th April 1999, two companies with similar science-based cultures and a shared vision of the pharmaceutical industry came together to form what’s now considered as one of the top ten pharma companies in the world: AstraZeneca.